A new clinical trial from Eli Lilly and Company suggests its experimental triple hormone drug, retatrutide, could become one ...

Stroke is a leading cause of death and disability worldwide, with staggering statistics that demand urgent attention. Every year, approximately 12.2 million new strokes are diagnosed globally, and one ...

A Cleveland Clinic study suggests GLP-1 weight loss drugs may help slow the spread of some obesity-related cancers.

GLP-1 medications were initially developed and prescribed to help manage blood sugar in people with Type 2 diabetes ...

Learn about the current medication options for managing type 2 diabetes and chronic kidney disease, including SGLT2 ...

GLP-1 drugs, such as Ozempic and Wegovy, may slow down the spread of obesity-related cancers, according to researchers ...

Credit: Getty Images Our easy-to-read fact sheets provide patients with an overview for type 2 diabetes medications that also induce weight loss. Our easy-to-read fact sheets provide clinicians with ...

The landscape of diabetes management is undergoing a remarkable transformation. Groundbreaking research has uncovered surprising cardiovascular benefits tied to modern medications, offering new hope ...

This year, celebrity gossip, a national shortage and eyebrow-raising clinical trials made household names of weight-loss and diabetes drugs like Ozempic, Wegovy and Mounjaro. The buzzy drugs belong to ...

Researchers at Stanford Medicine have reported a breakthrough in Type 1 diabetes research after successfully curing the ...